NCT05425290Completed
Emotion Regulation Training to Reduce Cardiovascular Disease Risk Among Depressed Young Adults in Southern Mississippi
Emotion Regulation Training to Reduce Cardiovascular Disease Risk Among Depressed Young Adults in Southern Mississippi: A Single-Session Design
Source: ClinicalTrials.gov · Last updated 14 May 2024
Brief summary (registry, in English)
The proposed study will investigate the utility of a single-session emotion regulation training to reduce CVD risk among young adults diagnosed with MDD living in Southern MS. Using an single-arm, non-randomized design, young adults aged 18-29 will undergo a single-session emotion regulation skills training. Before and immediately after the skills training session, participants will supply several biological metrics tied to CVD risk: resting HRV, inflammation (measured via c-reactive protein \[CRP\]), and blood pressure. Participants will provide the same biological metrics at a one-week follow-up visit to assess short-term sustained gains following the single-session intervention and complete a 7-day ecological momentary assessment (EMA) of their daily emotion regulation skills use and depressive symptoms between these two visits.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 20 Feb 2022
- Start date
- Aug 2022
- Primary completion date
- Dec 2023
- Lead sponsor
- University of Southern Mississippi
- Diseases
- Depression
- NCT number
- NCT05425290
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From Aug 2022 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Ongoing use of steroids (if use of steroids is temporary, individuals are eligible to participate 30 days after termination)
- Medication change in the past 30 days (individuals are eligible to participate 30 days after a medication change and may take advantage of delayed scheduling)
Other illness
- Presence of autoimmune and/or inflammatory diseases (e.g., rheumatoid arthritis, ulcerative colitis)
- Meets diagnostic criteria for a schizophrenia-spectrum disorder, substance use disorder, and/or bipolar disorder
- Presence of a cardiovascular disease (e.g., hypertension) or prescribed cardiovascular medications (e.g., beta blockers, blood pressure medication)
Other
- Not fluent in English
- Not able to provide informed consent
- Active suicidal ideation
Who the study is looking for
- Men and women ages 18-29
- Able to speak and read English
- Outpatient at the time of participation
- Able to provide informed consent
- Stable medications for 30 days or more
- Appropriate diagnoses:
- Meets diagnostic criteria for current major depressive disorder
Age in the registry: 18 years to 29 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Southern Mississippi Coordinator of this site? Confirm its status | Hattiesburg | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.